Publication | Closed Access

Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis

Cell-based Drug DeliveryNanomedicineDrug TargetingEngineeringPolymer-drug ConjugateNano-drug DeliveryTumor TargetingBiomedical EngineeringPharmacologyBone MetastasisBone-targeting Carrier